Chen, M. F., Butler, M. O., Ahnert, J. R., Hall, E. T., Eroglu, Z., Rose, A. A. N., Taylor, M. H., Beck, J. T., Shepard, D., Haggiagi, A., Chu, Q. S., Shapira-Frommer, R., Pezo, R. C., McArthur, G. A., Jackson-Fisher, A., Iacobucci, C., Wollenberg, L., Guo, X., Sturtz, K., Haq, R. (2026). Phase 1b study of a brain-penetrant MEK inhibitor, PF-07799544, plus next-generation BRAF dimer inhibitor, PF-07799933, in advanced
                    <i>BRAF</i>
                    -mutant melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9512